首页 / 院系成果 / 成果详情页

A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma  会议论文 期刊论文  

  • 编号：
    6297cc27-0723-421f-bf1b-a01b4332300e
  • 作者：
    Feng, Jifeng[1] Wu, Jianqiu[1] Song, Yongping[2] Su, Liping[3] Zhang, Mingzhi[4] Li, Wei[5] Hu, Yu[6] Zhang, Xiaohong[7] Gao, Yuhuan[8] Feng, Ru[9] Wang, Wei[10] Niu, Zuoxing[11] Peng, Jiewen[12] Li, Xiaolin[13] Ouyang, Xuenong[14] Wu, Changing[15] Zhang, Weijing[16] Zeng, Yun[17] Xiao, Zhen[18] Liang, Yingmin[19] Zhuang, Yongzhi[20] Wang, Jishi[21] Sun, Zimin[22] Bai, Hai[23] Cui, Tongjian[24]
  • 语种：
    英文
  • 期刊：
    BLOOD ISSN：0006-4971 2014 年 124 卷 21 期 ; DEC 6
  • 收录：
     
  • 推荐引用方式
    GB/T 7714：
    Feng Jifeng,Wu Jianqiu,Song Yongping, et al. A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma [J].BLOOD,2014,124(21).
  • APA：
    Feng Jifeng,Wu Jianqiu,Song Yongping,Su Liping,&Cui Tongjian.(2014).A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma .BLOOD,124(21).
  • MLA：
    Feng Jifeng, et al. "A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma" .BLOOD 124,21(2014).
  • 条目包含文件：
    文件类型：PDF,文件大小：
    正在加载全文
浏览次数：102 下载次数：0
分享到：
浏览次数：102
下载次数：0
打印次数：0

网站总浏览量： 次   

Copyright © 昆明医科大学

技术支持：北京同舟云网络信息技术有限公司

浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部